CClinicalTrials.gg
TerminatedNCT03259386Updated Dec 11, 2018

Movement and Sensation for Advanced Prosthetic Hands

An observational study in Amputation, sponsored by Mayo Clinic. Terminated at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-11.

Sponsored by Mayo Clinic · Observational

Why this study was terminated
Problem with obtaining microarrays, which are essential components needed to conduct this study.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to learn more information about nerves. This study is also designed to learn how the information in nerves could be used to develop new prosthetic devices.

Read the detailed description

The general design of the study is broken down into two parts: the pre- and post-implantation schedules:

During the 30 days before implantation the participant will be asked to take home a small computer with an Oculus Rift headset and Leap Motion hand tracker. The participant will be asked to use these items five (5) times a week for 30 minutes a session and interact with a displayed virtual reality environment. In this environment the participant will move their intact hand and the Leap Motion will display the hand movements in the virtual environment with the intact hand movements being mirrored between two hand facsimile. The participant will be instructed to move and stretch both their phantom and intact hand in a mirrored fashion. The purpose of these exercises are to allow the participant to become accustomed to the virtual reality setup (equipment and display) as well as providing a mirror box like effect where the virtual hand facsimile for their phantom hand is mapped to their body.

The second phase of the general design continues for 30-90 days post-implantation. We shall perform electrophysiological recordings from a single microelectrode array implanted into either the median, radial, or ulnar nerve. Neural signals (single and compound action potentials) evoked by variegated movements of the fingers and thumb will be recorded on the implanted microelectrode array. By recording electrical signals from the nerves the investigators hope to decode finger movements in real-time using machine learning algorithms. The participants will be asked to complete tasks in controlled virtual environment during the training phase. The virtual environment, which includes virtual arms and hands, will be presented to the participant via the Oculus rift, a pair of virtual reality goggles. The task will require recording the position of arms in space which will be accomplished using the Vicon motion capture system that will use infra-red reflecting markers attached to the participant's arms. The investigators will also use a marker-less motion capture system, Leap Motion, to track the specific movements of the intact hand. Post training, the investigators aim to perform real-time decoding of finger movements in the virtual reality environments.

02

Conditions studied

  • Amputation
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

These are patients that have previously undergone a transradial or transhumeral amputation.

Inclusion criteria

  1. Patient has previously undergone a transradial (below elbow) or transhumeral (above elbow) amputation.

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy
  2. Incarceration
  3. Inability to consent
  4. Serious, untreated comorbidity
  5. Patient is diagnosed with a medical condition(s) that seriously increase the risk of electrode implantation
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1 participant (actual)
Patient registry
No

Groups and cohorts

  • Transradial or Transhumeral amputees

    High-count microelectrode arrays are implanted into the upper limb peripheral nerves of transradial or transhumeral amputees.

    Device: Microelectrode array

Interventions

  • DeviceMicroelectrode array

    Microelectrode array implanted in area of amputation of either transradial or transhumeral amputees. This device is not designed to collect data on safety and effectiveness but rather, the device is a tool to assist in the sensory and motor properties of peripheral nerve stump fibers in amputees and is considered basic physiological research. This study was determined to be IDE exempt by the FDA; the study is considered basic physiological research.

05

What researchers measure

Primary outcomes

  1. Number of subjects for whom the investigators can decode finger movements

    High-count microelectrode arrays are implanted into upper limb peripheral nerves of transradial and transhumeral amputees. Direct micro-stimulation of peripheral nerves will be done using the microelectrode array.

    Time frame: From 44-104 days post-implantation

06

Study locations

2 sites
  • Mayo Clinic
    Phoenix, Arizona 85054, United States
  • Arizona State University
    Tempe, Arizona 85287, United States
07

Registry details

Key details

Study ID
NCT03259386
Lead sponsor
Mayo Clinic
Collaborators
United States Department of Defense, Arizona State University
Responsible party
Shelley S. Noland (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Aug 23, 2017
Start date
Sep 11, 2017
Primary completion
Oct 24, 2018
Completion
Oct 24, 2018
Last update
Dec 11, 2018

Study contacts

Shelley Noland, MD
principal investigator · Mayo Clinic

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion